CN105874503A - 用于自动的医疗产品或服务输送的设备、系统和方法 - Google Patents
用于自动的医疗产品或服务输送的设备、系统和方法 Download PDFInfo
- Publication number
- CN105874503A CN105874503A CN201480072246.8A CN201480072246A CN105874503A CN 105874503 A CN105874503 A CN 105874503A CN 201480072246 A CN201480072246 A CN 201480072246A CN 105874503 A CN105874503 A CN 105874503A
- Authority
- CN
- China
- Prior art keywords
- patient
- service
- input
- sensor
- medical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract description 98
- 229940127554 medical product Drugs 0.000 title claims description 89
- 238000012795 verification Methods 0.000 claims abstract description 17
- 230000036541 health Effects 0.000 claims description 64
- 238000003860 storage Methods 0.000 claims description 44
- 238000009826 distribution Methods 0.000 claims description 28
- 238000010200 validation analysis Methods 0.000 claims description 28
- 208000024891 symptom Diseases 0.000 claims description 23
- 230000003862 health status Effects 0.000 claims description 18
- 230000006870 function Effects 0.000 claims description 16
- 230000004044 response Effects 0.000 claims description 16
- 230000005540 biological transmission Effects 0.000 claims description 15
- 230000008859 change Effects 0.000 claims description 14
- 238000013480 data collection Methods 0.000 claims description 11
- 230000000007 visual effect Effects 0.000 claims description 10
- 238000005259 measurement Methods 0.000 claims description 9
- 238000001514 detection method Methods 0.000 claims description 5
- 238000007689 inspection Methods 0.000 claims description 5
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 3
- 238000013500 data storage Methods 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 2
- 210000001367 artery Anatomy 0.000 claims 1
- 210000003462 vein Anatomy 0.000 claims 1
- 239000000047 product Substances 0.000 description 100
- 239000003814 drug Substances 0.000 description 77
- 238000011156 evaluation Methods 0.000 description 43
- 230000015654 memory Effects 0.000 description 39
- 238000004891 communication Methods 0.000 description 37
- 210000003128 head Anatomy 0.000 description 29
- 229940079593 drug Drugs 0.000 description 23
- 208000002193 Pain Diseases 0.000 description 19
- 238000012360 testing method Methods 0.000 description 19
- 238000004590 computer program Methods 0.000 description 18
- 230000036407 pain Effects 0.000 description 17
- 230000005611 electricity Effects 0.000 description 16
- 210000004369 blood Anatomy 0.000 description 13
- 238000012545 processing Methods 0.000 description 13
- 239000008280 blood Substances 0.000 description 12
- 238000005516 engineering process Methods 0.000 description 11
- 239000000955 prescription drug Substances 0.000 description 11
- 230000008569 process Effects 0.000 description 11
- 230000037396 body weight Effects 0.000 description 10
- 230000000694 effects Effects 0.000 description 10
- 238000012544 monitoring process Methods 0.000 description 10
- 230000003287 optical effect Effects 0.000 description 10
- BRUQQQPBMZOVGD-XFKAJCMBSA-N Oxycodone Chemical compound O=C([C@@H]1O2)CC[C@@]3(O)[C@H]4CC5=CC=C(OC)C2=C5[C@@]13CCN4C BRUQQQPBMZOVGD-XFKAJCMBSA-N 0.000 description 9
- 238000004364 calculation method Methods 0.000 description 8
- 210000003491 skin Anatomy 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- 238000013475 authorization Methods 0.000 description 7
- 239000004615 ingredient Substances 0.000 description 7
- 230000029058 respiratory gaseous exchange Effects 0.000 description 7
- 206010020751 Hypersensitivity Diseases 0.000 description 6
- 208000026935 allergic disease Diseases 0.000 description 6
- 230000007815 allergy Effects 0.000 description 6
- 238000004166 bioassay Methods 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 238000013461 design Methods 0.000 description 6
- 230000033001 locomotion Effects 0.000 description 6
- 230000007246 mechanism Effects 0.000 description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 5
- 208000027418 Wounds and injury Diseases 0.000 description 5
- 230000000202 analgesic effect Effects 0.000 description 5
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 230000005520 electrodynamics Effects 0.000 description 5
- 239000008103 glucose Substances 0.000 description 5
- 208000015181 infectious disease Diseases 0.000 description 5
- 230000002452 interceptive effect Effects 0.000 description 5
- 238000011835 investigation Methods 0.000 description 5
- 229940105606 oxycontin Drugs 0.000 description 5
- 229910052760 oxygen Inorganic materials 0.000 description 5
- 239000001301 oxygen Substances 0.000 description 5
- YMHOBZXQZVXHBM-UHFFFAOYSA-N 2,5-dimethoxy-4-bromophenethylamine Chemical compound COC1=CC(CCN)=C(OC)C=C1Br YMHOBZXQZVXHBM-UHFFFAOYSA-N 0.000 description 4
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 4
- 241000545067 Venus Species 0.000 description 4
- 206010052428 Wound Diseases 0.000 description 4
- 230000006399 behavior Effects 0.000 description 4
- 230000036760 body temperature Effects 0.000 description 4
- 230000008878 coupling Effects 0.000 description 4
- 238000010168 coupling process Methods 0.000 description 4
- 238000005859 coupling reaction Methods 0.000 description 4
- 230000001419 dependent effect Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 210000002683 foot Anatomy 0.000 description 4
- 238000003384 imaging method Methods 0.000 description 4
- 230000006698 induction Effects 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 229940124636 opioid drug Drugs 0.000 description 4
- 229960002085 oxycodone Drugs 0.000 description 4
- 230000005855 radiation Effects 0.000 description 4
- 239000000523 sample Substances 0.000 description 4
- 230000011664 signaling Effects 0.000 description 4
- 239000013589 supplement Substances 0.000 description 4
- 238000001931 thermography Methods 0.000 description 4
- 206010044565 Tremor Diseases 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 229940125368 controlled substance Drugs 0.000 description 3
- 239000000599 controlled substance Substances 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 210000001508 eye Anatomy 0.000 description 3
- 230000001815 facial effect Effects 0.000 description 3
- 230000008921 facial expression Effects 0.000 description 3
- 210000003754 fetus Anatomy 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 210000004905 finger nail Anatomy 0.000 description 3
- 230000005021 gait Effects 0.000 description 3
- 210000004209 hair Anatomy 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 239000000820 nonprescription drug Substances 0.000 description 3
- 238000004806 packaging method and process Methods 0.000 description 3
- 230000002093 peripheral effect Effects 0.000 description 3
- 230000000704 physical effect Effects 0.000 description 3
- 230000035479 physiological effects, processes and functions Effects 0.000 description 3
- 238000009597 pregnancy test Methods 0.000 description 3
- 238000007639 printing Methods 0.000 description 3
- 239000003826 tablet Substances 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 2
- 206010004950 Birth mark Diseases 0.000 description 2
- 206010008479 Chest Pain Diseases 0.000 description 2
- 208000035473 Communicable disease Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 241000283073 Equus caballus Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 2
- 208000019802 Sexually transmitted disease Diseases 0.000 description 2
- 208000006011 Stroke Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 238000001467 acupuncture Methods 0.000 description 2
- 230000006978 adaptation Effects 0.000 description 2
- 239000000935 antidepressant agent Substances 0.000 description 2
- 229940005513 antidepressants Drugs 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 208000008784 apnea Diseases 0.000 description 2
- 229910052785 arsenic Inorganic materials 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000001149 cognitive effect Effects 0.000 description 2
- 230000006998 cognitive state Effects 0.000 description 2
- 230000005670 electromagnetic radiation Effects 0.000 description 2
- 239000010408 film Substances 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000000446 fuel Substances 0.000 description 2
- 230000005251 gamma ray Effects 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 210000004247 hand Anatomy 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 230000010247 heart contraction Effects 0.000 description 2
- 238000005534 hematocrit Methods 0.000 description 2
- 210000003677 hemocyte Anatomy 0.000 description 2
- 229940000351 hemocyte Drugs 0.000 description 2
- 229960001680 ibuprofen Drugs 0.000 description 2
- 230000010354 integration Effects 0.000 description 2
- 230000001788 irregular Effects 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 230000004899 motility Effects 0.000 description 2
- 230000003533 narcotic effect Effects 0.000 description 2
- 230000000474 nursing effect Effects 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 230000002688 persistence Effects 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- 230000035935 pregnancy Effects 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 239000003237 recreational drug Substances 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 210000001525 retina Anatomy 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 230000003068 static effect Effects 0.000 description 2
- 201000009032 substance abuse Diseases 0.000 description 2
- 239000010409 thin film Substances 0.000 description 2
- AHOUBRCZNHFOSL-YOEHRIQHSA-N (+)-Casbol Chemical compound C1=CC(F)=CC=C1[C@H]1[C@H](COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-YOEHRIQHSA-N 0.000 description 1
- CVOFKRWYWCSDMA-UHFFFAOYSA-N 2-chloro-n-(2,6-diethylphenyl)-n-(methoxymethyl)acetamide;2,6-dinitro-n,n-dipropyl-4-(trifluoromethyl)aniline Chemical compound CCC1=CC=CC(CC)=C1N(COC)C(=O)CCl.CCCN(CCC)C1=C([N+]([O-])=O)C=C(C(F)(F)F)C=C1[N+]([O-])=O CVOFKRWYWCSDMA-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 206010002653 Anosmia Diseases 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 208000000094 Chronic Pain Diseases 0.000 description 1
- 208000028698 Cognitive impairment Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 241000938605 Crocodylia Species 0.000 description 1
- 206010011469 Crying Diseases 0.000 description 1
- 208000019505 Deglutition disease Diseases 0.000 description 1
- 206010013700 Drug hypersensitivity Diseases 0.000 description 1
- 206010014020 Ear pain Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 208000002513 Flank pain Diseases 0.000 description 1
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 description 1
- 208000004044 Hypesthesia Diseases 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 206010027145 Melanocytic naevus Diseases 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 206010028748 Nasal obstruction Diseases 0.000 description 1
- 206010028836 Neck pain Diseases 0.000 description 1
- 208000007256 Nevus Diseases 0.000 description 1
- SNIOPGDIGTZGOP-UHFFFAOYSA-N Nitroglycerin Chemical compound [O-][N+](=O)OCC(O[N+]([O-])=O)CO[N+]([O-])=O SNIOPGDIGTZGOP-UHFFFAOYSA-N 0.000 description 1
- 239000000006 Nitroglycerin Substances 0.000 description 1
- 208000012488 Opiate Overdose Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- AHOUBRCZNHFOSL-UHFFFAOYSA-N Paroxetine hydrochloride Natural products C1=CC(F)=CC=C1C1C(COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-UHFFFAOYSA-N 0.000 description 1
- 208000000450 Pelvic Pain Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 241000276498 Pollachius virens Species 0.000 description 1
- 208000037656 Respiratory Sounds Diseases 0.000 description 1
- 101100412093 Schizosaccharomyces pombe (strain 972 / ATCC 24843) rec16 gene Proteins 0.000 description 1
- 206010040904 Skin odour abnormal Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 206010041925 Staphylococcal infections Diseases 0.000 description 1
- 206010046543 Urinary incontinence Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 235000009392 Vitis Nutrition 0.000 description 1
- 241000219095 Vitis Species 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 230000003044 adaptive effect Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 238000000540 analysis of variance Methods 0.000 description 1
- 210000003423 ankle Anatomy 0.000 description 1
- 235000019558 anosmia Nutrition 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 230000002686 anti-diuretic effect Effects 0.000 description 1
- 229940124538 antidiuretic agent Drugs 0.000 description 1
- 239000003160 antidiuretic agent Substances 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 238000013473 artificial intelligence Methods 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 206010064097 avian influenza Diseases 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- XEGGRYVFLWGFHI-UHFFFAOYSA-N bendiocarb Chemical compound CNC(=O)OC1=CC=CC2=C1OC(C)(C)O2 XEGGRYVFLWGFHI-UHFFFAOYSA-N 0.000 description 1
- 229910002056 binary alloy Inorganic materials 0.000 description 1
- 239000010836 blood and blood product Substances 0.000 description 1
- 238000009529 body temperature measurement Methods 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 238000004422 calculation algorithm Methods 0.000 description 1
- 210000001715 carotid artery Anatomy 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000009535 clinical urine test Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 208000010877 cognitive disease Diseases 0.000 description 1
- 208000030251 communication disease Diseases 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000011961 computed axial tomography Methods 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 239000003433 contraceptive agent Substances 0.000 description 1
- 230000002254 contraceptive effect Effects 0.000 description 1
- 230000009519 contusion Effects 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000013481 data capture Methods 0.000 description 1
- 238000013479 data entry Methods 0.000 description 1
- 238000003066 decision tree Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 201000005311 drug allergy Diseases 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 230000005662 electromechanics Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000004146 energy storage Methods 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 210000001061 forehead Anatomy 0.000 description 1
- 235000013569 fruit product Nutrition 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 210000002816 gill Anatomy 0.000 description 1
- 229960003711 glyceryl trinitrate Drugs 0.000 description 1
- 230000001339 gustatory effect Effects 0.000 description 1
- 230000003648 hair appearance Effects 0.000 description 1
- 230000037308 hair color Effects 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 238000012074 hearing test Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 244000144980 herd Species 0.000 description 1
- 208000012285 hip pain Diseases 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- 239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 description 1
- 208000034783 hypoesthesia Diseases 0.000 description 1
- 238000003709 image segmentation Methods 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000001453 impedance spectrum Methods 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 229910052738 indium Inorganic materials 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 238000003331 infrared imaging Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 230000009191 jumping Effects 0.000 description 1
- 208000024765 knee pain Diseases 0.000 description 1
- 238000009533 lab test Methods 0.000 description 1
- 208000010729 leg swelling Diseases 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000004973 liquid crystal related substance Substances 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 230000003137 locomotive effect Effects 0.000 description 1
- 230000006742 locomotor activity Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000005055 memory storage Effects 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- 208000015688 methicillin-resistant staphylococcus aureus infectious disease Diseases 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- 238000012806 monitoring device Methods 0.000 description 1
- 210000000282 nail Anatomy 0.000 description 1
- UZHSEJADLWPNLE-GRGSLBFTSA-N naloxone Chemical compound O=C([C@@H]1O2)CC[C@@]3(O)[C@H]4CC5=CC=C(O)C2=C5[C@@]13CCN4CC=C UZHSEJADLWPNLE-GRGSLBFTSA-N 0.000 description 1
- 229960004127 naloxone Drugs 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000003401 opiate antagonist Substances 0.000 description 1
- 239000013307 optical fiber Substances 0.000 description 1
- 230000005693 optoelectronics Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000037324 pain perception Effects 0.000 description 1
- 229960005489 paracetamol Drugs 0.000 description 1
- 229960002296 paroxetine Drugs 0.000 description 1
- 230000005622 photoelectricity Effects 0.000 description 1
- 239000000902 placebo Substances 0.000 description 1
- 229940068196 placebo Drugs 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- ZLMJMSJWJFRBEC-OUBTZVSYSA-N potassium-40 Chemical compound [40K] ZLMJMSJWJFRBEC-OUBTZVSYSA-N 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 210000001747 pupil Anatomy 0.000 description 1
- 239000000700 radioactive tracer Substances 0.000 description 1
- VCBKOGTZQNFBOT-ATZDWAIDSA-N ram-325 Chemical compound C1C(=O)CC[C@@]2(O)[C@H]3CC4=CC=C(OC)C(OC)=C4[C@]21CCN3C VCBKOGTZQNFBOT-ATZDWAIDSA-N 0.000 description 1
- 230000008707 rearrangement Effects 0.000 description 1
- 230000007115 recruitment Effects 0.000 description 1
- 230000002207 retinal effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 230000009183 running Effects 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 230000011218 segmentation Effects 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 210000000697 sensory organ Anatomy 0.000 description 1
- 230000037075 skin appearance Effects 0.000 description 1
- 230000007958 sleep Effects 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 238000012109 statistical procedure Methods 0.000 description 1
- 231100000736 substance abuse Toxicity 0.000 description 1
- 208000011117 substance-related disease Diseases 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000026676 system process Effects 0.000 description 1
- 210000003371 toe Anatomy 0.000 description 1
- 238000003325 tomography Methods 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 229910052720 vanadium Inorganic materials 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 230000004393 visual impairment Effects 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 230000009184 walking Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 210000000707 wrist Anatomy 0.000 description 1
Classifications
-
- G—PHYSICS
- G07—CHECKING-DEVICES
- G07F—COIN-FREED OR LIKE APPARATUS
- G07F17/00—Coin-freed apparatus for hiring articles; Coin-freed facilities or services
- G07F17/0092—Coin-freed apparatus for hiring articles; Coin-freed facilities or services for assembling and dispensing of pharmaceutical articles
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06Q—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q50/00—Information and communication technology [ICT] specially adapted for implementation of business processes of specific business sectors, e.g. utilities or tourism
- G06Q50/10—Services
- G06Q50/22—Social work or social welfare, e.g. community support activities or counselling services
-
- G—PHYSICS
- G07—CHECKING-DEVICES
- G07F—COIN-FREED OR LIKE APPARATUS
- G07F9/00—Details other than those peculiar to special kinds or types of apparatus
- G07F9/001—Interfacing with vending machines using mobile or wearable devices
-
- G—PHYSICS
- G07—CHECKING-DEVICES
- G07F—COIN-FREED OR LIKE APPARATUS
- G07F9/00—Details other than those peculiar to special kinds or types of apparatus
- G07F9/009—User recognition or proximity detection
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
- G16H20/13—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered from dispensers
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/20—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the management or administration of healthcare resources or facilities, e.g. managing hospital staff or surgery rooms
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
- Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Primary Health Care (AREA)
- Medical Informatics (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Business, Economics & Management (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- General Business, Economics & Management (AREA)
- Tourism & Hospitality (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Strategic Management (AREA)
- Marketing (AREA)
- Human Resources & Organizations (AREA)
- Economics (AREA)
- Theoretical Computer Science (AREA)
- Child & Adolescent Psychology (AREA)
- Medical Treatment And Welfare Office Work (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14/079,778 | 2013-11-14 | ||
| US14/079,857 US9864842B2 (en) | 2013-11-14 | 2013-11-14 | Devices, systems, and methods for automated medical product or service delivery |
| US14/079,857 | 2013-11-14 | ||
| US14/079,823 | 2013-11-14 | ||
| US14/079,823 US10289806B2 (en) | 2013-11-14 | 2013-11-14 | Devices, systems, and methods for automated medical product or service delivery |
| US14/079,778 US20150134345A1 (en) | 2013-11-14 | 2013-11-14 | Devices, systems, and methods for automated medical product or service delivery |
| PCT/US2014/064848 WO2015073375A1 (fr) | 2013-11-14 | 2014-11-10 | Dispositifs, systèmes et procédés pour la délivrance automatisée de produits ou de services médicaux |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105874503A true CN105874503A (zh) | 2016-08-17 |
Family
ID=53057920
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201480072246.8A Pending CN105874503A (zh) | 2013-11-14 | 2014-11-10 | 用于自动的医疗产品或服务输送的设备、系统和方法 |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP3069314A4 (fr) |
| JP (1) | JP2017501481A (fr) |
| KR (1) | KR20160085876A (fr) |
| CN (1) | CN105874503A (fr) |
| AU (1) | AU2014348901A1 (fr) |
| CA (1) | CA2930697A1 (fr) |
| WO (1) | WO2015073375A1 (fr) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018176935A1 (fr) * | 2017-04-01 | 2018-10-04 | 南京阿凡达机器人科技有限公司 | Plateforme et procédé de gestion de santé basés sur un robot orienté enfants |
| CN109147893A (zh) * | 2017-06-16 | 2019-01-04 | 沃尔格林公司 | 用于处理对于由个体提取的处方药物的技术 |
| CN109147896A (zh) * | 2018-07-20 | 2019-01-04 | 陈宇庆 | 基于多功能药箱的主动健康服务系统 |
| CN110799089A (zh) * | 2016-12-29 | 2020-02-14 | 阿诺·乔梅尔 | 与机器并且与配有医疗装置的人员相关的安全 |
| CN113823373A (zh) * | 2021-10-27 | 2021-12-21 | 云智道智慧医疗科技(广州)有限公司 | 一种眼化学伤智能诊断急救通道系统 |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102014105058A1 (de) * | 2014-04-09 | 2015-10-15 | Stephanie Ittstein | Vorrichtung zu einer Herstellung und/oder zu einer Verabreichung |
| US11475451B2 (en) | 2017-03-31 | 2022-10-18 | Bayer Healthcare Llc | Biometric authentication for, and secure electronic tracking of, restricted over-the-counter drug sales |
| US20180293352A1 (en) * | 2017-04-10 | 2018-10-11 | COTA, Inc. | System and Method for Decision-Making for Determining Initiation and Type of Treatment for Patients with a Progressive Illness |
| JP2019053511A (ja) * | 2017-09-14 | 2019-04-04 | グローリー株式会社 | 処理システム及び処理管理方法 |
| WO2019166997A1 (fr) | 2018-03-02 | 2019-09-06 | Bayer Healthcare Llc | Authentification, établissement et suivi de l'éligibilité d'un patient pour acheter un médicament sans ordonnance |
| KR101938250B1 (ko) * | 2018-04-04 | 2019-01-14 | 주식회사 큐엠아이티 | 훈련 전/후 상태 정보 기반 부상 예방 시스템, 장치 및 방법 |
| WO2020075159A1 (fr) | 2018-10-09 | 2020-04-16 | Inovytec Medical Solutions Ltd | Système de traitement personnalisé immédiat d'un patient en urgence médicale |
| KR102136215B1 (ko) * | 2019-05-16 | 2020-07-21 | 주식회사 어니언스 | 의료기기 관리 방법 및 그 시스템 |
| KR20220117651A (ko) | 2021-02-17 | 2022-08-24 | 주식회사 엘브리지 | 건강 상품 주문 및 판매를 위한 모바일 플랫폼 제공 시스템 및 그 운용방법 |
| KR20220117650A (ko) | 2021-02-17 | 2022-08-24 | 주식회사 엘브리지 | 키오스크기반 병원 및 요양시설 건강 상품 판매 시스템 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1388939A (zh) * | 2000-07-14 | 2003-01-01 | 松下电器产业株式会社 | 医疗信息系统、患者用终端装置和媒体 |
| CN101911136A (zh) * | 2007-11-08 | 2010-12-08 | 葛兰素史密斯克莱有限责任公司 | 医药产品分配系统和方法 |
| CN102880776A (zh) * | 2011-07-12 | 2013-01-16 | 李卫云 | 一种物联网医疗系统 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7685026B1 (en) * | 2000-05-05 | 2010-03-23 | Automed Technologies, Inc. | Method of tracking and dispensing medical items |
| US7870007B1 (en) * | 2002-07-09 | 2011-01-11 | Ncr Corporation | System and method of determining interactions between medicines |
| US7087018B2 (en) * | 2002-11-13 | 2006-08-08 | Siemens Medical Solutions Usa, Inc. | System and method for real-time feature sensitivity analysis based on contextual information |
| US7616111B2 (en) * | 2005-06-20 | 2009-11-10 | Carestream Health, Inc. | System to monitor the ingestion of medicines |
| US7689318B2 (en) * | 2005-08-19 | 2010-03-30 | Lonnie Draper | Inventory control and prescription dispensing system |
| CA2565408C (fr) * | 2005-10-25 | 2013-01-08 | Mckesson Automation Systems, Inc. | Interface adaptative pour systemes de distribution de produits |
| US20070106129A1 (en) * | 2005-11-07 | 2007-05-10 | Cardiac Pacemakers, Inc. | Dietary monitoring system for comprehensive patient management |
| US8467897B2 (en) * | 2007-12-19 | 2013-06-18 | Rxsafe Llc | Pharmaceutical storage and retrieval system and methods of storing and retrieving pharmaceuticals |
| KR101051263B1 (ko) * | 2009-03-04 | 2011-07-21 | 연세대학교 산학협력단 | 만성질환자를 위한 재택 원격 가정 간호 서비스 시스템 및 방법 |
| US8721543B2 (en) * | 2011-01-12 | 2014-05-13 | Arsham Andy Saffarian | Data analytics system |
| US9043217B2 (en) * | 2011-03-31 | 2015-05-26 | HealthSpot Inc. | Medical kiosk and method of use |
| US9443370B2 (en) * | 2012-03-26 | 2016-09-13 | Omnicare, Inc. | Method and apparatus for onsite distribution of medications and medical supplies |
| WO2013157851A1 (fr) * | 2012-04-18 | 2013-10-24 | (주)제이브이엠 | Système de distribution de médicament et procédé de commande de ce système |
-
2014
- 2014-11-10 JP JP2016531003A patent/JP2017501481A/ja active Pending
- 2014-11-10 CA CA2930697A patent/CA2930697A1/fr not_active Abandoned
- 2014-11-10 EP EP14862648.4A patent/EP3069314A4/fr not_active Ceased
- 2014-11-10 KR KR1020167015755A patent/KR20160085876A/ko not_active Application Discontinuation
- 2014-11-10 CN CN201480072246.8A patent/CN105874503A/zh active Pending
- 2014-11-10 AU AU2014348901A patent/AU2014348901A1/en not_active Abandoned
- 2014-11-10 WO PCT/US2014/064848 patent/WO2015073375A1/fr active Application Filing
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1388939A (zh) * | 2000-07-14 | 2003-01-01 | 松下电器产业株式会社 | 医疗信息系统、患者用终端装置和媒体 |
| CN101911136A (zh) * | 2007-11-08 | 2010-12-08 | 葛兰素史密斯克莱有限责任公司 | 医药产品分配系统和方法 |
| CN102880776A (zh) * | 2011-07-12 | 2013-01-16 | 李卫云 | 一种物联网医疗系统 |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110799089A (zh) * | 2016-12-29 | 2020-02-14 | 阿诺·乔梅尔 | 与机器并且与配有医疗装置的人员相关的安全 |
| WO2018176935A1 (fr) * | 2017-04-01 | 2018-10-04 | 南京阿凡达机器人科技有限公司 | Plateforme et procédé de gestion de santé basés sur un robot orienté enfants |
| CN109147893A (zh) * | 2017-06-16 | 2019-01-04 | 沃尔格林公司 | 用于处理对于由个体提取的处方药物的技术 |
| US11749392B1 (en) | 2017-06-16 | 2023-09-05 | Walgreen Co. | Technology for processing prescription medications for pickup by individuals |
| CN109147896A (zh) * | 2018-07-20 | 2019-01-04 | 陈宇庆 | 基于多功能药箱的主动健康服务系统 |
| CN113823373A (zh) * | 2021-10-27 | 2021-12-21 | 云智道智慧医疗科技(广州)有限公司 | 一种眼化学伤智能诊断急救通道系统 |
Also Published As
| Publication number | Publication date |
|---|---|
| EP3069314A1 (fr) | 2016-09-21 |
| CA2930697A1 (fr) | 2015-05-21 |
| EP3069314A4 (fr) | 2017-06-14 |
| KR20160085876A (ko) | 2016-07-18 |
| WO2015073375A1 (fr) | 2015-05-21 |
| JP2017501481A (ja) | 2017-01-12 |
| AU2014348901A1 (en) | 2016-06-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105874503A (zh) | 用于自动的医疗产品或服务输送的设备、系统和方法 | |
| US20180089394A1 (en) | Devices, systems, and methods for automated medical product or service delivery | |
| US10289806B2 (en) | Devices, systems, and methods for automated medical product or service delivery | |
| US20190272725A1 (en) | Pharmacovigilance systems and methods | |
| Sufrin | Jailcare: Finding the safety net for women behind bars | |
| US9460264B2 (en) | Devices, systems, and methods for automated data collection | |
| US20210319895A1 (en) | Apparatus and method for providing healthcare services remotely or virtually with or using an electronic healthcare record and/or a communication network | |
| Krukowski et al. | Measuring weight with electronic scales in clinical and research settings during the coronavirus disease 2019 pandemic | |
| US20160157735A1 (en) | Techniques for near real time wellness monitoring using a wrist-worn device | |
| JP5689617B2 (ja) | 通信ネットワークを利用した医師指示管理システム | |
| US20150134345A1 (en) | Devices, systems, and methods for automated medical product or service delivery | |
| KR20140039055A (ko) | 컴플라이언스를 보장하기 위한 방법들 및 시스템들 | |
| WO2019070763A1 (fr) | Système de formation par apprentissage machine à médiation par un soignant | |
| US20230223142A1 (en) | Apparatus and method for providing healthcare services remotely or virtually with or using an electronic healthcare record and/or a communication network | |
| Chai et al. | Ingestible electronic sensors to measure instantaneous medication adherence: A narrative review | |
| Taramasco et al. | Improvement in quality of life with use of ambient-assisted living: clinical trial with older persons in the Chilean population | |
| US20230326615A1 (en) | Apparatus and method for providing healthcare services remotely or virtually with or using an electronic healthcare record and/or a communication network | |
| Richins | Emerging technologies in healthcare | |
| Lim et al. | Medication adherence using non-intrusive wearable sensors | |
| Harkness | Bridging the Uncompensated Caregiver Gap: Does Technology Provide an Ethically and Legally Viable Answer | |
| Dhamanti et al. | Smart home healthcare for chronic disease management: A scoping review | |
| Sadiku et al. | Emerging Technologies in Healthcare | |
| Zon et al. | Context-aware medical systems within healthcare environments: A systematic scoping review to identify subdomains and significant medical contexts | |
| US20230238152A1 (en) | Apparatus and method for providing healthcare services remotely or virtually with or using an electronic healthcare record and/or a communication network | |
| Malvey et al. | mHealth products, markets, and trends |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1227520 Country of ref document: HK |
|
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160817 |
|
| RJ01 | Rejection of invention patent application after publication | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1227520 Country of ref document: HK |